b27 Search Results


corio cd b27  (JULABO GmbH)
90
JULABO GmbH corio cd b27
Corio Cd B27, supplied by JULABO GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/corio cd b27/product/JULABO GmbH
Average 90 stars, based on 1 article reviews
corio cd b27 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
b27  (MedChemExpress)
95
MedChemExpress b27
B27, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/b27/product/MedChemExpress
Average 95 stars, based on 1 article reviews
b27 - by Bioz Stars, 2026-03
95/100 stars
  Buy from Supplier
ifnγ 158gd  (fluidigm)
93
fluidigm ifnγ 158gd
Ifnγ 158gd, supplied by fluidigm, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/ifnγ 158gd/product/fluidigm
Average 93 stars, based on 1 article reviews
ifnγ 158gd - by Bioz Stars, 2026-03
93/100 stars
  Buy from Supplier
n2 b27 medium  (Proteintech)
93
Proteintech n2 b27 medium
N2 B27 Medium, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/n2 b27 medium/product/Proteintech
Average 93 stars, based on 1 article reviews
n2 b27 medium - by Bioz Stars, 2026-03
93/100 stars
  Buy from Supplier
165ho  (fluidigm)
93
fluidigm 165ho

165ho, supplied by fluidigm, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/165ho/product/fluidigm
Average 93 stars, based on 1 article reviews
165ho - by Bioz Stars, 2026-03
93/100 stars
  Buy from Supplier
anti hla b27  (OriGene)
90
OriGene anti hla b27
(A) ARS staining of mineralization in AS MSCs transduced with shHLA-B or shCtrl under osteogenic induction with quantification (B). (C) Immunoblot analyses showing the expression of RARB and TNAP in AS MSCs expressing shHLA-B or shCtrl at day 7 under osteogenic induction. (D) Immunoblot showing <t>HLA-B27</t> expressions of control MSCs transduced with pLAS2w or pLAS2w-HLA-B27. (E) ARS staining of control MSCs transduced with control lentiviral vector (pLAS2w) or a vector expressing HLA-B27 (pLAS2w-HLA-B27) with quantification (F). (G) Immunoblot analyses showing RARB and TNAP expressions in control MSCs transduced with pLAS2w or pLAS2w-HLA-B27. All experiments done in the AS patient group and the control group are from AS MSCs (A1, A2, and A3) and control MSCs (C1, C2, and C3), respectively, with at least 2–3 experimental repeats. Data are the mean ± SEM. ***P < 0.001; ****P < 0.0001 by 2-tailed Student’s t test (2 groups) or 1-way ANOVA, followed by Tukey’s HSD test. Representative images from AS (A1) MSCs are shown in C. Scale bars: 200 μm (A and E).
Anti Hla B27, supplied by OriGene, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti hla b27/product/OriGene
Average 90 stars, based on 1 article reviews
anti hla b27 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
ifn  (fluidigm)
93
fluidigm ifn
(A) ARS staining of mineralization in AS MSCs transduced with shHLA-B or shCtrl under osteogenic induction with quantification (B). (C) Immunoblot analyses showing the expression of RARB and TNAP in AS MSCs expressing shHLA-B or shCtrl at day 7 under osteogenic induction. (D) Immunoblot showing <t>HLA-B27</t> expressions of control MSCs transduced with pLAS2w or pLAS2w-HLA-B27. (E) ARS staining of control MSCs transduced with control lentiviral vector (pLAS2w) or a vector expressing HLA-B27 (pLAS2w-HLA-B27) with quantification (F). (G) Immunoblot analyses showing RARB and TNAP expressions in control MSCs transduced with pLAS2w or pLAS2w-HLA-B27. All experiments done in the AS patient group and the control group are from AS MSCs (A1, A2, and A3) and control MSCs (C1, C2, and C3), respectively, with at least 2–3 experimental repeats. Data are the mean ± SEM. ***P < 0.001; ****P < 0.0001 by 2-tailed Student’s t test (2 groups) or 1-way ANOVA, followed by Tukey’s HSD test. Representative images from AS (A1) MSCs are shown in C. Scale bars: 200 μm (A and E).
Ifn, supplied by fluidigm, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/ifn/product/fluidigm
Average 93 stars, based on 1 article reviews
ifn - by Bioz Stars, 2026-03
93/100 stars
  Buy from Supplier
anti hla b7 b27 pe rea176  (Miltenyi Biotec)
94
Miltenyi Biotec anti hla b7 b27 pe rea176
(A) ARS staining of mineralization in AS MSCs transduced with shHLA-B or shCtrl under osteogenic induction with quantification (B). (C) Immunoblot analyses showing the expression of RARB and TNAP in AS MSCs expressing shHLA-B or shCtrl at day 7 under osteogenic induction. (D) Immunoblot showing <t>HLA-B27</t> expressions of control MSCs transduced with pLAS2w or pLAS2w-HLA-B27. (E) ARS staining of control MSCs transduced with control lentiviral vector (pLAS2w) or a vector expressing HLA-B27 (pLAS2w-HLA-B27) with quantification (F). (G) Immunoblot analyses showing RARB and TNAP expressions in control MSCs transduced with pLAS2w or pLAS2w-HLA-B27. All experiments done in the AS patient group and the control group are from AS MSCs (A1, A2, and A3) and control MSCs (C1, C2, and C3), respectively, with at least 2–3 experimental repeats. Data are the mean ± SEM. ***P < 0.001; ****P < 0.0001 by 2-tailed Student’s t test (2 groups) or 1-way ANOVA, followed by Tukey’s HSD test. Representative images from AS (A1) MSCs are shown in C. Scale bars: 200 μm (A and E).
Anti Hla B7 B27 Pe Rea176, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti hla b7 b27 pe rea176/product/Miltenyi Biotec
Average 94 stars, based on 1 article reviews
anti hla b7 b27 pe rea176 - by Bioz Stars, 2026-03
94/100 stars
  Buy from Supplier
mouse anti human hla b27 fitc  (Bio-Rad)
93
Bio-Rad mouse anti human hla b27 fitc
(A) ARS staining of mineralization in AS MSCs transduced with shHLA-B or shCtrl under osteogenic induction with quantification (B). (C) Immunoblot analyses showing the expression of RARB and TNAP in AS MSCs expressing shHLA-B or shCtrl at day 7 under osteogenic induction. (D) Immunoblot showing <t>HLA-B27</t> expressions of control MSCs transduced with pLAS2w or pLAS2w-HLA-B27. (E) ARS staining of control MSCs transduced with control lentiviral vector (pLAS2w) or a vector expressing HLA-B27 (pLAS2w-HLA-B27) with quantification (F). (G) Immunoblot analyses showing RARB and TNAP expressions in control MSCs transduced with pLAS2w or pLAS2w-HLA-B27. All experiments done in the AS patient group and the control group are from AS MSCs (A1, A2, and A3) and control MSCs (C1, C2, and C3), respectively, with at least 2–3 experimental repeats. Data are the mean ± SEM. ***P < 0.001; ****P < 0.0001 by 2-tailed Student’s t test (2 groups) or 1-way ANOVA, followed by Tukey’s HSD test. Representative images from AS (A1) MSCs are shown in C. Scale bars: 200 μm (A and E).
Mouse Anti Human Hla B27 Fitc, supplied by Bio-Rad, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mouse anti human hla b27 fitc/product/Bio-Rad
Average 93 stars, based on 1 article reviews
mouse anti human hla b27 fitc - by Bioz Stars, 2026-03
93/100 stars
  Buy from Supplier
rs13202464 hla b27  (Thermo Fisher)
86
Thermo Fisher rs13202464 hla b27
(A) ARS staining of mineralization in AS MSCs transduced with shHLA-B or shCtrl under osteogenic induction with quantification (B). (C) Immunoblot analyses showing the expression of RARB and TNAP in AS MSCs expressing shHLA-B or shCtrl at day 7 under osteogenic induction. (D) Immunoblot showing <t>HLA-B27</t> expressions of control MSCs transduced with pLAS2w or pLAS2w-HLA-B27. (E) ARS staining of control MSCs transduced with control lentiviral vector (pLAS2w) or a vector expressing HLA-B27 (pLAS2w-HLA-B27) with quantification (F). (G) Immunoblot analyses showing RARB and TNAP expressions in control MSCs transduced with pLAS2w or pLAS2w-HLA-B27. All experiments done in the AS patient group and the control group are from AS MSCs (A1, A2, and A3) and control MSCs (C1, C2, and C3), respectively, with at least 2–3 experimental repeats. Data are the mean ± SEM. ***P < 0.001; ****P < 0.0001 by 2-tailed Student’s t test (2 groups) or 1-way ANOVA, followed by Tukey’s HSD test. Representative images from AS (A1) MSCs are shown in C. Scale bars: 200 μm (A and E).
Rs13202464 Hla B27, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/rs13202464 hla b27/product/Thermo Fisher
Average 86 stars, based on 1 article reviews
rs13202464 hla b27 - by Bioz Stars, 2026-03
86/100 stars
  Buy from Supplier
heating bath circulator  (JULABO GmbH)
90
JULABO GmbH heating bath circulator
(A) ARS staining of mineralization in AS MSCs transduced with shHLA-B or shCtrl under osteogenic induction with quantification (B). (C) Immunoblot analyses showing the expression of RARB and TNAP in AS MSCs expressing shHLA-B or shCtrl at day 7 under osteogenic induction. (D) Immunoblot showing <t>HLA-B27</t> expressions of control MSCs transduced with pLAS2w or pLAS2w-HLA-B27. (E) ARS staining of control MSCs transduced with control lentiviral vector (pLAS2w) or a vector expressing HLA-B27 (pLAS2w-HLA-B27) with quantification (F). (G) Immunoblot analyses showing RARB and TNAP expressions in control MSCs transduced with pLAS2w or pLAS2w-HLA-B27. All experiments done in the AS patient group and the control group are from AS MSCs (A1, A2, and A3) and control MSCs (C1, C2, and C3), respectively, with at least 2–3 experimental repeats. Data are the mean ± SEM. ***P < 0.001; ****P < 0.0001 by 2-tailed Student’s t test (2 groups) or 1-way ANOVA, followed by Tukey’s HSD test. Representative images from AS (A1) MSCs are shown in C. Scale bars: 200 μm (A and E).
Heating Bath Circulator, supplied by JULABO GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/heating bath circulator/product/JULABO GmbH
Average 90 stars, based on 1 article reviews
heating bath circulator - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
b27 miltenyi  (Miltenyi Biotec)
94
Miltenyi Biotec b27 miltenyi
(A) ARS staining of mineralization in AS MSCs transduced with shHLA-B or shCtrl under osteogenic induction with quantification (B). (C) Immunoblot analyses showing the expression of RARB and TNAP in AS MSCs expressing shHLA-B or shCtrl at day 7 under osteogenic induction. (D) Immunoblot showing <t>HLA-B27</t> expressions of control MSCs transduced with pLAS2w or pLAS2w-HLA-B27. (E) ARS staining of control MSCs transduced with control lentiviral vector (pLAS2w) or a vector expressing HLA-B27 (pLAS2w-HLA-B27) with quantification (F). (G) Immunoblot analyses showing RARB and TNAP expressions in control MSCs transduced with pLAS2w or pLAS2w-HLA-B27. All experiments done in the AS patient group and the control group are from AS MSCs (A1, A2, and A3) and control MSCs (C1, C2, and C3), respectively, with at least 2–3 experimental repeats. Data are the mean ± SEM. ***P < 0.001; ****P < 0.0001 by 2-tailed Student’s t test (2 groups) or 1-way ANOVA, followed by Tukey’s HSD test. Representative images from AS (A1) MSCs are shown in C. Scale bars: 200 μm (A and E).
B27 Miltenyi, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/b27 miltenyi/product/Miltenyi Biotec
Average 94 stars, based on 1 article reviews
b27 miltenyi - by Bioz Stars, 2026-03
94/100 stars
  Buy from Supplier

Image Search Results


Journal: Cell reports

Article Title: Molecular Signatures of Dengue Virus-Specific IL-10/IFN-γ Co-producing CD4 T Cells and Their Association with Dengue Disease

doi: 10.1016/j.celrep.2019.11.098

Figure Lengend Snippet:

Article Snippet: IFNg, 165Ho , Fluidigm , Cat#3165002B; Clone B27.

Techniques: Recombinant, Staining, Activation Assay, Software

(A) ARS staining of mineralization in AS MSCs transduced with shHLA-B or shCtrl under osteogenic induction with quantification (B). (C) Immunoblot analyses showing the expression of RARB and TNAP in AS MSCs expressing shHLA-B or shCtrl at day 7 under osteogenic induction. (D) Immunoblot showing HLA-B27 expressions of control MSCs transduced with pLAS2w or pLAS2w-HLA-B27. (E) ARS staining of control MSCs transduced with control lentiviral vector (pLAS2w) or a vector expressing HLA-B27 (pLAS2w-HLA-B27) with quantification (F). (G) Immunoblot analyses showing RARB and TNAP expressions in control MSCs transduced with pLAS2w or pLAS2w-HLA-B27. All experiments done in the AS patient group and the control group are from AS MSCs (A1, A2, and A3) and control MSCs (C1, C2, and C3), respectively, with at least 2–3 experimental repeats. Data are the mean ± SEM. ***P < 0.001; ****P < 0.0001 by 2-tailed Student’s t test (2 groups) or 1-way ANOVA, followed by Tukey’s HSD test. Representative images from AS (A1) MSCs are shown in C. Scale bars: 200 μm (A and E).

Journal: The Journal of Clinical Investigation

Article Title: HLA-B27–mediated activation of TNAP phosphatase promotes pathogenic syndesmophyte formation in ankylosing spondylitis

doi: 10.1172/JCI125212

Figure Lengend Snippet: (A) ARS staining of mineralization in AS MSCs transduced with shHLA-B or shCtrl under osteogenic induction with quantification (B). (C) Immunoblot analyses showing the expression of RARB and TNAP in AS MSCs expressing shHLA-B or shCtrl at day 7 under osteogenic induction. (D) Immunoblot showing HLA-B27 expressions of control MSCs transduced with pLAS2w or pLAS2w-HLA-B27. (E) ARS staining of control MSCs transduced with control lentiviral vector (pLAS2w) or a vector expressing HLA-B27 (pLAS2w-HLA-B27) with quantification (F). (G) Immunoblot analyses showing RARB and TNAP expressions in control MSCs transduced with pLAS2w or pLAS2w-HLA-B27. All experiments done in the AS patient group and the control group are from AS MSCs (A1, A2, and A3) and control MSCs (C1, C2, and C3), respectively, with at least 2–3 experimental repeats. Data are the mean ± SEM. ***P < 0.001; ****P < 0.0001 by 2-tailed Student’s t test (2 groups) or 1-way ANOVA, followed by Tukey’s HSD test. Representative images from AS (A1) MSCs are shown in C. Scale bars: 200 μm (A and E).

Article Snippet: The primary antibodies were mouse anti–active dephosphorylated β-catenin (clone 8E7; 1:500; Merck Millipore), rabbit anti–phosphorylated (serine 463/465) Smad 1/5/8 (clone 41D10; 1:250; Cell Signaling Technology), rabbit anti-TNAP (clone EPR4477; 1:500; Abcam), rabbit anti-RARB (catalog ab53161; 1:500; Abcam), goat anti-LEF1 (clone N-17; 1:500; Santa Cruz Biotechnology), rabbit anti-IRE1 (catalog ab37073; 1:1000; Abcam), rabbit anti–phosphorylated (serine 724) IRE1 (catalog ab4818; 1:500; Abcam), rabbit anti-XBP1 (catalog ab37152; 1:2000; Abcam), anti–HLA-B27 (clone HLA-ABC-m3; 1:300; Origene), anti–HLA-B7 [clone EPR2623( 2 ); 1:500; Abcam], rabbit anti-GAPDH (catalog GTX100118; 1:10,000; GeneTex), and mouse anti–β-actin (catalog MA5-15739; 1:10,000; Thermo Fisher Scientific).

Techniques: Staining, Transduction, Western Blot, Expressing, Plasmid Preparation

(A) Unfolded or misfolded HCs were immunoprecipitated (IP) from lysates of AS MSCs and control MSCs with HC10 antibody, followed by immunoblotting with HLA-B27 and anti-BiP antibodies. In AS MSCs, monomers of HLA-B27 HCs and dimers of disulfide-linked HLA-B27 HCs are indicated by an arrow and an arrowhead, respectively. (B and C) Immunoblot showing the expressions of p-IRE1 (B) and sXBP1 (C) protein in AS and control MSCs at day 7 under osteogenic induction. (D) Immunoblot showing the expressions of p-IRE1 and sXBP1 in AS MSCs transduced with shHLA-B or shCtrl. (E) Immunoblot showing the expressions of p-IRE1 and sXBP1 protein in control MSCs transduced with pLAS2w-HLA-B27 or pLAS2w. (F) ChIP assay showing sXBP1 binding at fragments (Frags) 1, 2, 3, 6, and 7 within 1400 bp upstream of the RARB transcriptional start site in AS MSCs. RARB 3′-untranslated region (3′UTR) was used as the negative control locus. (G) Immunoblot showing the expressions of RARB and TNAP in AS MSCs expressing shXBP1 or shCtrl. (H) ARS staining of mineralization in AS MSCs transduced with shXBP1 or shCtrl under osteogenic induction with quantification (I). All experiments done in the AS patient group and control group are from AS MSCs (A1, A2, and A3) and control MSCs (C1, C2, and C3), respectively, with at least 2–3 experimental repeats. Data are the mean ± SEM. **P < 0.05; ***P < 0.001; ****P < 0.0001 by 2-tailed Student’s t test (2 groups) or ****P < 0.0001 by 1-way ANOVA, followed by Tukey’s HSD test. Representative immunoblots from AS (A1) MSCs are shown in G.

Journal: The Journal of Clinical Investigation

Article Title: HLA-B27–mediated activation of TNAP phosphatase promotes pathogenic syndesmophyte formation in ankylosing spondylitis

doi: 10.1172/JCI125212

Figure Lengend Snippet: (A) Unfolded or misfolded HCs were immunoprecipitated (IP) from lysates of AS MSCs and control MSCs with HC10 antibody, followed by immunoblotting with HLA-B27 and anti-BiP antibodies. In AS MSCs, monomers of HLA-B27 HCs and dimers of disulfide-linked HLA-B27 HCs are indicated by an arrow and an arrowhead, respectively. (B and C) Immunoblot showing the expressions of p-IRE1 (B) and sXBP1 (C) protein in AS and control MSCs at day 7 under osteogenic induction. (D) Immunoblot showing the expressions of p-IRE1 and sXBP1 in AS MSCs transduced with shHLA-B or shCtrl. (E) Immunoblot showing the expressions of p-IRE1 and sXBP1 protein in control MSCs transduced with pLAS2w-HLA-B27 or pLAS2w. (F) ChIP assay showing sXBP1 binding at fragments (Frags) 1, 2, 3, 6, and 7 within 1400 bp upstream of the RARB transcriptional start site in AS MSCs. RARB 3′-untranslated region (3′UTR) was used as the negative control locus. (G) Immunoblot showing the expressions of RARB and TNAP in AS MSCs expressing shXBP1 or shCtrl. (H) ARS staining of mineralization in AS MSCs transduced with shXBP1 or shCtrl under osteogenic induction with quantification (I). All experiments done in the AS patient group and control group are from AS MSCs (A1, A2, and A3) and control MSCs (C1, C2, and C3), respectively, with at least 2–3 experimental repeats. Data are the mean ± SEM. **P < 0.05; ***P < 0.001; ****P < 0.0001 by 2-tailed Student’s t test (2 groups) or ****P < 0.0001 by 1-way ANOVA, followed by Tukey’s HSD test. Representative immunoblots from AS (A1) MSCs are shown in G.

Article Snippet: The primary antibodies were mouse anti–active dephosphorylated β-catenin (clone 8E7; 1:500; Merck Millipore), rabbit anti–phosphorylated (serine 463/465) Smad 1/5/8 (clone 41D10; 1:250; Cell Signaling Technology), rabbit anti-TNAP (clone EPR4477; 1:500; Abcam), rabbit anti-RARB (catalog ab53161; 1:500; Abcam), goat anti-LEF1 (clone N-17; 1:500; Santa Cruz Biotechnology), rabbit anti-IRE1 (catalog ab37073; 1:1000; Abcam), rabbit anti–phosphorylated (serine 724) IRE1 (catalog ab4818; 1:500; Abcam), rabbit anti-XBP1 (catalog ab37152; 1:2000; Abcam), anti–HLA-B27 (clone HLA-ABC-m3; 1:300; Origene), anti–HLA-B7 [clone EPR2623( 2 ); 1:500; Abcam], rabbit anti-GAPDH (catalog GTX100118; 1:10,000; GeneTex), and mouse anti–β-actin (catalog MA5-15739; 1:10,000; Thermo Fisher Scientific).

Techniques: Immunoprecipitation, Western Blot, Transduction, Binding Assay, Negative Control, Expressing, Staining